DaVita Inc
DVA141.510USD
+1.009+0.72%
Handelsschluss 04/29, 16:00（ET）Kurse um 15 Minuten verzögert
11.40BMarktkapitalisierung
12.17KGV TTM
mehr Informationen über DaVita Inc Unternehmen
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Unternehmensinformationen
Unternehmens-codeDVA
Name des UnternehmensDaVita Inc
IPO-datumOct 31, 1995
Gegründet am1994
CEOMr. Javier J. Rodriguez
Anzahl der mitarbeiter76000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
Addresse2000 16th St
StadtDENVER
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl80202-5117
Telefon13105362668
Websitehttps://www.davita.com/
Unternehmens-codeDVA
IPO-datumOct 31, 1995
Gegründet am1994
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Mr. Charles G. (Chuck) Berg, J.D.
Mr. Charles G. (Chuck) Berg, J.D.
Independent Director
Independent Director
26.68K
+1.33%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.23K
+1.40%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
16.63K
+38.27%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
12.85K
+2.79%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
12.31K
-27.55%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Mr. Charles G. (Chuck) Berg, J.D.
Mr. Charles G. (Chuck) Berg, J.D.
Independent Director
Independent Director
26.68K
+1.33%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.23K
+1.40%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
6.37B
49.74%
Patient service - Commercial
4.03B
31.46%
Patient service - Other government
1.06B
8.28%
Patient service - Medicaid and Managed Medicaid
863.95M
6.74%
Other - Medicare and Medicare Advantage
463.73M
3.62%
Other
19.70M
0.15%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
6.37B
49.74%
Patient service - Commercial
4.03B
31.46%
Patient service - Other government
1.06B
8.28%
Patient service - Medicaid and Managed Medicaid
863.95M
6.74%
Other - Medicare and Medicare Advantage
463.73M
3.62%
Other
19.70M
0.15%
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Berkshire Hathaway Inc.
45.72%
The Vanguard Group, Inc.
6.76%
BlackRock Institutional Trust Company, N.A.
3.80%
State Street Global Advisors (US)
3.05%
Weschler (R Ted)
2.84%
Other
37.84%
Aktionärsstatistik
Aktionäre
Anteil
Berkshire Hathaway Inc.
45.72%
The Vanguard Group, Inc.
6.76%
BlackRock Institutional Trust Company, N.A.
3.80%
State Street Global Advisors (US)
3.05%
Weschler (R Ted)
2.84%
Other
37.84%
Art
Aktionäre
Anteil
Holding Company
45.73%
Investment Advisor
22.27%
Investment Advisor/Hedge Fund
21.39%
Individual Investor
4.65%
Hedge Fund
2.78%
Pension Fund
1.91%
Research Firm
1.63%
Bank and Trust
1.09%
Sovereign Wealth Fund
0.11%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
1238
78.42M
98.02%
-4.90M
2024Q4
1260
79.70M
99.28%
-3.76M
2024Q3
1214
80.97M
98.10%
-3.96M
2024Q2
1180
82.28M
96.62%
-4.32M
2024Q1
1166
84.15M
95.98%
-4.07M
2023Q4
1163
84.91M
95.56%
-3.04M
2023Q3
1159
85.40M
93.52%
-3.20M
2023Q2
1164
84.27M
92.30%
-4.64M
2023Q1
1168
84.01M
92.60%
-5.13M
2022Q4
1198
83.55M
92.31%
-8.33M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Berkshire Hathaway Inc.
35.14M
43.93%
-953.09K
-2.64%
Feb 19, 2025
The Vanguard Group, Inc.
5.19M
6.49%
-167.41K
-3.12%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
2.92M
3.65%
-212.41K
-6.79%
Dec 31, 2024
State Street Global Advisors (US)
2.34M
2.93%
-68.93K
-2.86%
Dec 31, 2024
Weschler (R Ted)
2.18M
2.73%
--
--
Aug 06, 2024
Invesco Capital Management LLC
1.24M
1.54%
+285.57K
+30.05%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.15M
1.44%
-14.40K
-1.24%
Dec 31, 2024
LSV Asset Management
1.03M
1.29%
-25.40K
-2.41%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
902.42K
1.13%
-76.86K
-7.85%
Dec 31, 2024
Rodriguez (Javier J)
894.08K
1.12%
+18.82K
+2.15%
Mar 15, 2025
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Invesco Dorsey Wright Healthcare Momentum ETF
3.43%
Strategas Global Policy Opportunities ETF
2.15%
SPDR S&P Health Care Services ETF
2.14%
Aztlan Global Stock Selection DM SMID ETF
1.72%
First Trust Health Care Alphadex Fund
1.71%
Invesco S&P 500 Equal Weight Health Care ETF
1.51%
Pacer US Cash Cows Growth ETF
1.4%
LG QRAFT AI-Powered US Large Cap Core ETF
1.3%
LeaderShares AlphaFactor US Core ETF
1.26%
Global X Aging Population ETF
1.1%
Mehr Anzeigen
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil3.43%
Strategas Global Policy Opportunities ETF
Anteil2.15%
SPDR S&P Health Care Services ETF
Anteil2.14%
Aztlan Global Stock Selection DM SMID ETF
Anteil1.72%
First Trust Health Care Alphadex Fund
Anteil1.71%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.51%
Pacer US Cash Cows Growth ETF
Anteil1.4%
LG QRAFT AI-Powered US Large Cap Core ETF
Anteil1.3%
LeaderShares AlphaFactor US Core ETF
Anteil1.26%
Global X Aging Population ETF
Anteil1.1%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten